| Typicality: | 0.366 |
| Saliency: | 0.271 |
| currently | 3 | temporal |
| around the world | 2 | location |
| therapy → be approved in → europe | 7 |
| therapy → be approved in → the european union | 7 |
| negative | neutral | positive |
| 0.060 | 0.656 | 0.284 |
| Raw frequency | 14 |
| Normalized frequency | 0.271 |
| Modifier score | 0.500 |
| Perplexity | 92.581 |